Latest Noumi (ASX:NOU) News

Noumi Limited reported a 13.4% revenue increase in Q2 FY26 driven by strong growth in its Dairy and Nutritionals and Plant-based Milks segments, despite a $4.5 million operating cash outflow impacted by legal expenses. The company’s Milklab brand continues to gain traction both domestically and internationally.

Noumi Limited reported a 13% rise in adjusted operating EBITDA for FY25, driven by strong growth in its Milklab plant-based milk brand, while preparing for a significant convertible note maturity in 2027.

Noumi Limited reported a 9.0% increase in revenue to $162.4 million for Q1 FY26, driven by strong growth in Dairy and Nutritionals and Milklab plant-based milks, while successfully closing legacy legal matters.

Noumi Limited has completed its $11.56 million payment towards a $43 million class action settlement, now unconditional following Victorian Supreme Court approval. The payment was made by insurers, activating legal releases for the company.

Noumi Limited reported a 13% rise in adjusted operating EBITDA for FY25, driven by strong growth in its plant-based milks and dairy segments. The company has resolved legacy litigation issues and is now focused on navigating the $610 million convertible note maturity due in 2027.

Noumi Limited reported modest revenue growth and a significant rise in adjusted EBITDA for FY25, driven by its Milklab brand’s strong performance and a continued turnaround in its Dairy & Nutritionals segment. The company also resolved all legacy legal issues, positioning itself for future growth.

Noumi Limited has posted a significant $150 million loss for the year ending June 2025, driven by non-cash charges and raising questions about its financial stability.

Noumi Limited reported a nearly flat Q4 FY25 revenue with mixed segment performances and flagged a net loss for the year amid legacy legal expenses. The company highlights growth in its Milklab brand and export sales while managing significant convertible note obligations.

Noumi Limited has received Victorian Supreme Court approval for its $43 million class action settlement, closing a significant chapter tied to past financial restatements. The company’s insurer will cover its $11.56 million contribution, while legal costs will impact FY25 results.

Noumi Limited reported a 2.8% revenue increase to $141.4 million in Q3 FY25, buoyed by gains in its Dairy and Nutritionals segment, while managing legacy legal costs and maintaining strong cash flow.

Noumi Limited’s Q2 FY25 results reveal a resilient plant-based milks segment driving growth, even as traditional dairy and nutritionals face margin pressures amid a challenging market.